Value Creation Capital
Bilthoven, Netherlands27
730K
22
1.42
4
0.19
3
- Stages of investment
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
- Geo focus
- Check size
- Up to 500K
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 27
- Lead investments
- 4
- Exits
- 3
- Rounds per year
- 1.42
- Follow on index
- 0.19
- Investments by industry
- Software (12)
- Information Technology (8)
- Cyber Security (5)
- Enterprise Software (5)
- Privacy (5) Show 35 more
- Investments by region
- Netherlands (13)
- The Netherlands (11)
- United States (2)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 0.52
- Avg. company exit year
- 10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Fastmicro | 30 May 2024 | Seed | North Brabant, Noord-Brabant, Netherlands | ||
| NetDialog | 01 Jun 2009 | Software, Information Technology, Enterprise Software, Application Performance Management | Early Stage Venture | Utrecht, Utrecht, Netherlands | |
| Seiratherm | 31 Jan 2017 | Biotechnology, Health Care, Hospital, Medical Device | Early Stage Venture | 413K | Germany, Bavaria, Germany |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bioxodes | Oct 12, 2025 | Biopharmaceutical, Clinical stage, Thrombotic and inflammatory diseases | - | 5500000 EUR |  Gosselies, |
| Augustine Therapeutics | Mar 24, 2025 | Biotech, Biotechnology, Cardio-metabolic diseases, Cardio-metabolic Diseases, Cardiometabolic Diseases, Charcot-Marie-Tooth (CMT) disease, HDAC6 Inhibition, Neurodegenerative diseases, Neurodegenerative Diseases, Neurological Disorders, Neuromuscular diseases, Neuromuscular Diseases, Small-Molecule Inhibitors, Therapies | - | 77700000 EUR | Leuven, |
| AdipoPharma | Nov 12, 2024 | Biotech, Type 2 diabetes drug, Type 2 diabetes treatment | - | - |  Strasbourg, |
| Santero | Jun 7, 2023 | Antibiotics, Multi-drug resistant infections | Early stage | 8000000 EUR | Charleroi |
| AdipoPharma | Jan 23, 2023 | Biotech, Novel Therapeutics, Type 2 Diabetes Treatment | Early stage | - | Strasbourg, Grand Est |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.